Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of liver metastases on clinical efficacy of first-line programmed death-1 inhibitor plus chemotherapy in esophageal squamous cell carcinoma: A post hoc analysis of ASTRUM-007 and meta-analysis.
Gao J, Song Y, Kou X, Tan Z, Zhang S, Sun M, Zhou J, Fan M, Zhang M, Song Y, Li S, Yuan Y, Zhuang W, Zhang J, Zhang L, Jiang H, Gu K, Ye H, Ke Y, Qi X, Wang Q, Zhu J, Huang J. Gao J, et al. Among authors: ke y. Cancer Med. 2024 May;13(10):e7203. doi: 10.1002/cam4.7203. Cancer Med. 2024. PMID: 38769930 Free PMC article.
First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial.
Song Y, Zhang B, Xin D, Kou X, Tan Z, Zhang S, Sun M, Zhou J, Fan M, Zhang M, Song Y, Li S, Yuan Y, Zhuang W, Zhang J, Zhang L, Jiang H, Gu K, Ye H, Ke Y, Li J, Wang Q, Zhu J, Huang J; ASTRUM-007 investigators. Song Y, et al. Among authors: ke y. Nat Med. 2023 Feb;29(2):473-482. doi: 10.1038/s41591-022-02179-2. Epub 2023 Feb 2. Nat Med. 2023. PMID: 36732627 Free PMC article. Clinical Trial.
First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trial.
Wang ZX, Peng J, Liang X, Cheng Y, Deng Y, Chen K, Zhang M, Zhang J, Wang W, Cao B, Jin Y, Sun M, Lin Y, Luo S, Li Z, Yang L, Ke Y, Yu H, Li J, Wang Q, Zhu J, Wang F, Xu RH. Wang ZX, et al. Among authors: ke y. Med. 2024 Sep 13;5(9):1150-1163.e3. doi: 10.1016/j.medj.2024.05.009. Epub 2024 Jun 12. Med. 2024. PMID: 38870931 Clinical Trial.
Development and validation of a sensitive liquid chromatography-tandem mass spectrometry method for the determination of paeoniflorin in rat brain and its application to pharmacokinetic study.
Xia SM, Shen R, Sun XY, Shen LL, Yang YM, Ke Y, Wang Y, Chen DY, Han XM. Xia SM, et al. Among authors: ke y. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Sep 15;857(1):32-9. doi: 10.1016/j.jchromb.2007.06.022. Epub 2007 Jun 30. J Chromatogr B Analyt Technol Biomed Life Sci. 2007. PMID: 17631428
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.
CURRENT-OASIS 7 Investigators; Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, Fox KA, Granger CB, Jolly S, Joyner CD, Rupprecht HJ, Widimsky P, Afzal R, Pogue J, Yusuf S. CURRENT-OASIS 7 Investigators, et al. N Engl J Med. 2010 Sep 2;363(10):930-42. doi: 10.1056/NEJMoa0909475. N Engl J Med. 2010. PMID: 20818903 Free article. Clinical Trial.
Targeting KAT7 inhibits the progression of colorectal cancer.
Wang H, Guan T, Hu R, Huang Z, Liang Z, Lin X, Qiu Y, Liao P, Guo X, Ke Y, Zhang H, Ou C, Li Y. Wang H, et al. Among authors: ke y. Theranostics. 2025 Jan 2;15(4):1478-1495. doi: 10.7150/thno.106085. eCollection 2025. Theranostics. 2025. PMID: 39816686 Free PMC article.
3,294 results